# OnCo record nct00433511 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct00433511/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct00433511", "NCT00433511" ;
  schema:name "E5103 adjuvant chemotherapy with or without bevacizumab"@en ;
  schema:alternateName "Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer"@en ;
  schema:description "E5103 compares chemotherapy after breast surgery with or without bevacizumab. It measures whether adding the drug changes the chance of cancer recurrence."@en ;
  schema:url <https://onco.cc/trials/nct00433511/> ;
  schema:dateModified "2026-10-10"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00433511>, <https://clinicaltrials.ucsf.edu/trial/NCT00433511> ;
  onco:status "active" ;
  onco:tag "ucsf-breast-coverage", "interventional" ;
  onco:phase "3" ;
  schema:startDate "2007-11-02" ;
  onco:cancers <https://onco.cc/cancers/breast-cancer/> ;
  onco:drugs <https://onco.cc/drugs/bevacizumab/>, <https://onco.cc/drugs/cyclophosphamide/>, <https://onco.cc/drugs/doxorubicin/>, <https://onco.cc/drugs/paclitaxel/> ;
  onco:institutions <https://onco.cc/institutions/ucsf/> .